Don’t Jump to Topical Vtama or Zoryve for Psoriasis

October 2022

Vtama (tapinarof) and Zoryve (roflumilast) will be two new once-daily Rx creams for psoriasis.

Both will be touted as steroid-free options that are safe for long-term use, even on thin-skinned areas (face, groin, etc).

But they each reduce inflammation differently.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote